Publication date: Available online 17 August 2026 Source: Ophthalmology Glaucoma Author(s): Shon B. Shmushkevich, Sandi Bajrami, Zachary A. Grand, Jonathan D. Tijerina, Basil K. Williams, Adam L. Rothman
Risk of New Glaucoma Diagnosis and Surgery for Patients with Intravitreal Injections in the TriNetX Database. // Ophthalmology Glaucoma. – URL: https://www.sciencedirect.com/science/article/pii/S2589419626001353?dgcid=rss_sd_all
Risk of New Glaucoma Diagnosis and Surgery for Patients with Intravitreal Injections in the TriNetX Database. Ophthalmology Glaucoma. https://www.sciencedirect.com/science/article/pii/S2589419626001353?dgcid=rss_sd_all
“Risk of New Glaucoma Diagnosis and Surgery for Patients with Intravitreal Injections in the TriNetX Database.” Ophthalmology Glaucoma.
@article{article90363,
title = {Risk of New Glaucoma Diagnosis and Surgery for Patients with Intravitreal Injections in the TriNetX Database},
journal = {Ophthalmology Glaucoma},
url = {https://www.sciencedirect.com/science/article/pii/S2589419626001353?dgcid=rss_sd_all}
}
Abstract Purpose To compare the efficacy of intravitreal dexamethasone (DEX) implant‐based regimen versus ranibizumab‐based regimen for managing retinal exudation and complications in stage 3 Coats' disease. Methods Thirty‐seven eyes...
Abstract Foundation models are rapidly emerging as a major development in ophthalmic artificial intelligence, largely because they can achieve strong downstream performance with fewer labelled images than conventional supervised models,...
Abstract Purpose To evaluate intraretinal fluid (IRF) volume dynamics after switching from aflibercept 2 mg to faricimab in eyes with diabetic macular oedema (DME), stratified by prior response to aflibercept. Methods This retrospective...